The National Association of Specialty Pharmacy (NASP) applauded President Donald Trump’s plan to cut prescription drug costs, but added it wants to see much-needed reforms are underway to support specialty pharmacy patients.
“Today we heard the President say we must stop the profiteering at the expense of our seniors and the Medicare program, and the NASP couldn’t agree more,” NASP Excutive Director Sheila Arquette said. “It is high time the administration collaborate with Congress and put an end to the anti-competitive practices of the largest vertically-integrated pharmacy benefit managers.”
Arquette said the latter practices “threaten access to medications for seniors living with severe and rare complex conditions.”
To read the full report on Pharmabiz.Com, click here.